SciELO - Scientific Electronic Library Online

 
vol.38 issue2Indices of diagnostic abdominal ultrasonography in acute appendicitis: influence of gender and physical constitution, time evolution of the disease and experience of radiologistStudy of arterial pattern of 200 renal pedicle through angiotomography author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista do Colégio Brasileiro de Cirurgiões

Print version ISSN 0100-6991

Abstract

ROZENOWICZ, Renato de Lima et al. Interval cytoreduction in advanced ovarian cancer: Santa Casa São Paulo experience. Rev. Col. Bras. Cir. [online]. 2011, vol.38, n.2, pp.112-115. ISSN 0100-6991.  https://doi.org/10.1590/S0100-69912011000200008.

OBJECTIVE: To analyze the interval cytoreduction in patients with advanced ovarian cancer. METHODS: A prospective study was carried out with 25 patients with advanced ovarian cancer (stages IIIC or IV) who underwent interval cytoreduction. Nonresectability criteria were based on the ones from Gustave-Rousy Institute. After induction chemotherapy and rapprochement we evaluated the rates of optimal surgery and the morbidity and mortality of the procedure in addition to the overall survival at two years. RESULTS: optimal cytoreduction was possible in 17 patients (68%) with morbidity and mortality from 8% to 4%. The overall survival at two years was 68%. CONCLUSION: The interval cytoreduction is an alternative therapy in advanced ovarian cancer, allowing optimal cytoreduction opportunity to patients suffering from unresectable disease, with acceptable morbidity and mortality.

Keywords : Ovarian Neoplasms; Neoplasm stanging; Survival amalysis; Female.

        · abstract in Portuguese     · text in English | Portuguese     · English ( pdf ) | Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License